an-orthotopic-resectional-mouse-model-of-pancreatic-cancer

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

There is a lack of satisfactory animal models to study adjuvant and/or neoadjuvant therapy in patients being considered for surgery of pancreatic cancer ...

University of New South Wales

Ingham Institute for Applied Medical Research

Westmead hospital

University of Sydney

Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis. The aim of this study was to identify novel protein signatures that would predict clinical outcomes in a large cohort of patients with ACC based on data from previous gene expression microarray studies.

Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers.

Pancreatic stellate cells (PSCs) are known to play an important role in facilitating pancreatic cancer progression-both in terms of local tumour growth as well as the establishment of metastases. We have previously demonstrated that PSCs from the primary cancer seed to distant metastatic sites. We therefore hypothesise that PSCs circulate along with pancreatic cancer cells (circulating tumour cells-CTCs) to help create a growth permissive microenvironment at distant metastatic sites. This review aims to explore the concept of circulating PSCs in pancreatic cancer and suggests future directions for research in this area.

Circulating pancreatic stellate (stromal) cells in pancreatic cancer-a fertile area for novel research.

Pancreatic stellate cells (PSCs) play an integral role in the pathogenesis of pancreatitis and pancreatic cancer. With the developing knowledge of this important cell type, we are at the cusp of developing effective therapies for the above diseases based upon targeting the PSC and modulating its function.

Pancreatic stellate cells: what's new?

Stromal-tumour interactions facilitate pancreatic cancer (PC) progression. The hepatocyte growth factor (HGF)/c-MET pathway is upregulated in PC and mediates the interaction between cancer cells and stromal pancreatic stellate cells (PSCs). This study assessed the effect of HGF/c-MET inhibition plus gemcitabine (G) on the progression of advanced PC.

Tony C. Y. Pang

Pancreatic Research Group,
South Western Sydney Clinical School,
Pancreatic Research Group, South Western Sydney Clinical School

University of New South Wales

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Tony C. Y. Pang

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Pancreatic Research Group,South Western Sydney Clinical School,Pancreatic Research Group, South Western Sydney Clinical School

University of New South Wales

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Pancreatic Research Group,
South Western Sydney Clinical School,
Pancreatic Research Group, South Western Sydney Clinical School